Cargando…

Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression

Application of RNA interference (RNAi) in the clinic has improved with the development of novel delivery reagents (e.g., lipidoids). Although RNAi promises a therapeutic approach at silencing gene expression, practical methods for enhancing gene production still remain a challenge. Previously, we re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Place, Robert F, Wang, Ji, Noonan, Emily J, Meyers, Rachel, Manoharan, Muthiah, Charisse, Klaus, Duncan, Rick, Huang, Vera, Wang, Xiaoling, Li, Long-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381590/ https://www.ncbi.nlm.nih.gov/pubmed/23343884 http://dx.doi.org/10.1038/mtna.2012.5

Ejemplares similares

Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells
por: Khare, Purva, et al.
Publicado: (2021)

Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
por: de Groot, Anne Marit, et al.
Publicado: (2018)

Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection
por: Ma, Feihe, et al.
Publicado: (2020)

In situ cancer vaccination using lipidoid nanoparticles
por: Chen, Jinjin, et al.
Publicado: (2021)

Structure–Activity Relationships of Cationic Lipidoids against Escherichia coli
por: Jennings, James, et al.
Publicado: (2023)

Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
por: Ball, Rebecca L., et al.
Publicado: (2015)

Study the lipidoid nanoparticle mediated genome editing protein delivery using 3D intestinal tissue model
por: Yang, Tao, et al.
Publicado: (2021)

Combinatorial Screening of Cationic Lipidoids Reveals How Molecular Conformation Affects Membrane-Targeting Antimicrobial Activity
por: Jennings, James, et al.
Publicado: (2023)

Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021)

Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters
por: Watts, Jonathan K., et al.
Publicado: (2010)

Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity
por: Dolina, Joseph S, et al.
Publicado: (2013)

The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation
por: Mobin, Mehrpouya B., et al.
Publicado: (2016)

Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
por: Chan, Amy, et al.
Publicado: (2015)

miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells
por: Noonan, Emily J., et al.
Publicado: (2010)

Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
por: Engelbeen, Sarah, et al.
Publicado: (2023)

Next generation patient-derived prostate cancer xenograft models
por: Lin, Dong, et al.
Publicado: (2014)

Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts
por: Tang, Renyan, et al.
Publicado: (2021)

Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic Acid
por: Sidana, Abhinav, et al.
Publicado: (2012)

Chemistry, structure and function of approved oligonucleotide therapeutics
por: Egli, Martin, et al.
Publicado: (2023)

Pharmacokinetics and tissue distribution of PGG–paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts
por: Wang, Xinghe, et al.
Publicado: (2009)

HDACs and the senescent phenotype of WI-38 cells
por: Place, Robert F, et al.
Publicado: (2005)

Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation
por: Wang, Xiaoling, et al.
Publicado: (2012)

Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021)

Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo
por: Jahns, Hartmut, et al.
Publicado: (2021)

Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors
por: Loiseau, Alexis, et al.
Publicado: (2019)

Recapitulation of prostate tissue cell type-specific transcriptomes by an in vivo primary prostate tissue xenograft model
por: Gross, Nelson T., et al.
Publicado: (2020)

Astaxanthin Inhibits PC-3 Xenograft Prostate Tumor Growth in Nude Mice
por: Ni, Xiaofeng, et al.
Publicado: (2017)

Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs
por: Schlegel, Mark K, et al.
Publicado: (2021)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

Characterization of prostate cancer cell progression in zebrafish xenograft model
por: Xu, Wei, et al.
Publicado: (2017)

Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017)

Modulation of thermal stability can enhance the potency of siRNA
por: Addepalli, Haripriya, et al.
Publicado: (2010)

Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
por: Kohli, Manish, et al.
Publicado: (2015)

Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
por: Sinclair, Paul. B., et al.
Publicado: (2018)

Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy.
por: Bogden, A. E., et al.
Publicado: (1996)

Acyclic (S)-glycol nucleic acid (S-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency
por: Egli, Martin, et al.
Publicado: (2023)

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
por: Wang, Piwen, et al.
Publicado: (2016)

Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer
por: Lange, Tobias, et al.
Publicado: (2018)

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
por: Hagtvet, Eirik, et al.
Publicado: (2011)

Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
por: Zins, Karin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t5nind0rsiipshef4dvq1ps8on